Pharmacokinetics and pharmacodynamics of anticoagulants in paediatric patients.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Works matching IS 03125963 AND DT 2013 AND VI 52 AND IP 11
Results: 12
1
2
Drug interactions with the newer antiepileptic drugs (AEDs)--part 1: pharmacokinetic and pharmacodynamic interactions between AEDs.
- Published in:
- 2013
- By:
- Publication type:
- journal article
3
Population pharmacokinetics of sifalimumab, an investigational anti-interferon-α monoclonal antibody, in systemic lupus erythematosus.
- Published in:
- 2013
- By:
- Publication type:
- journal article
4
Population pharmacokinetics of JNJ-37822681, a selective fast-dissociating dopamine D₂-receptor antagonist, in healthy subjects and subjects with schizophrenia and dose selection based on simulated D₂-receptor occupancy.
- Published in:
- 2013
- By:
- Publication type:
- journal article
5
Pharmacokinetics of Oral Recombinant Human Parathyroid Hormone [rhPTH(1-31)NH] in Postmenopausal Women with Osteoporosis.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 11, p. 995, doi. 10.1007/s40262-013-0083-4
- By:
- Publication type:
- Article
6
Pharmacokinetics and Pharmacodynamics of Anticoagulants in Paediatric Patients.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 11, p. 967, doi. 10.1007/s40262-013-0094-1
- By:
- Publication type:
- Article
7
Pharmacokinetics of oral recombinant human parathyroid hormone [rhPTH(1-31)NH₂] in postmenopausal women with osteoporosis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
8
Breath Tests to Phenotype Drug Disposition in Oncology.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 11, p. 919, doi. 10.1007/s40262-013-0099-9
- By:
- Publication type:
- Article
9
Population Pharmacokinetics of Sifalimumab, an Investigational Anti-Interferon-α Monoclonal Antibody, in Systemic Lupus Erythematosus.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 11, p. 1017, doi. 10.1007/s40262-013-0085-2
- By:
- Publication type:
- Article
10
Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 11, p. 981, doi. 10.1007/s40262-013-0093-2
- By:
- Publication type:
- Article
11
Population Pharmacokinetics of JNJ-37822681, a Selective Fast-Dissociating Dopamine D-Receptor Antagonist, in Healthy Subjects and Subjects with Schizophrenia and Dose Selection Based on Simulated D-Receptor Occupancy.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 11, p. 1005, doi. 10.1007/s40262-013-0084-3
- By:
- Publication type:
- Article
12
Drug Interactions with the Newer Antiepileptic Drugs (AEDs)-Part 1: Pharmacokinetic and Pharmacodynamic Interactions Between AEDs.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 11, p. 927, doi. 10.1007/s40262-013-0087-0
- By:
- Publication type:
- Article